- Home
- NUTX vs MDXG Comparison
NUTX vs MDXG Comparison
Compare NUTX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUTX | MDXG |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NUTX | MDXG |
|---|---|---|
| Price | $152.95 | $5.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $252.50 | $11.00 |
| AVG Volume (30 Days) | 151.0K | ★ 931.7K |
| Earning Date | 11-19-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 17.98 | 0.27 |
| Revenue | ★ $981,195,633.00 | $393,442,000.00 |
| Revenue This Year | $108.77 | $19.13 |
| Revenue Next Year | $3.69 | $2.11 |
| P/E Ratio | ★ $8.50 | $20.07 |
| Revenue Growth | ★ 236.03 | 14.77 |
| 52 Week Low | $32.80 | $5.39 |
| 52 Week High | $193.07 | $9.36 |
Technical Indicators
Market Signals| Indicator | NUTX | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.27 | 21.91 |
| Support Level | $146.82 | $5.55 |
| Resistance Level | $192.00 | $6.50 |
| Average True Range (ATR) | 16.17 | 0.22 |
| MACD | -3.61 | -0.11 |
| Stochastic Oscillator | 10.16 | 2.55 |
Price Performance
Historical ComparisonAbout NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.